This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can The Uptrend Continue for Kemper (KMPR)?
by Zacks Equity Research
Investors certainly have to be happy with Kemper Corporation (KMPR) and its short term performance
Radian Group (RDN) Surges: Stock Moves 8.5% Higher
by Zacks Equity Research
Radian Group (RDN) was a big mover last session, as the company saw its shares rise more than 8% on the day amid huge volumes.
Company News for May 1, 2018
by Zacks Equity Research
Companies In The News are: AHGP,MCD,KMPR,TEN
Insurers??? Q1 Earnings Roster for Apr 30: L, CNA, KMPR, MCY
by Zacks Equity Research
A favorable operating environment, fundamental strength of insurers and a lower tax incidence should drive first-quarter performance.
Should You Buy Kemper (KMPR) Ahead of Earnings?
by Zacks Equity Research
Kemper (KMPR) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Can Higher Revenues Boost CME Group's (CME) Q1 Earnings?
by Zacks Equity Research
Solid revenues and volume expansion are likely to drive CME Group's (CME) Q1.
Principal Financial (PFG) Q1 Earnings: What's in Store?
by Zacks Equity Research
Higher revenues and improved AUM are likely to aid Principal Financial's (PFG) Q1. However, rise in expenses might be a dampener.
Cincinnati Financial's (CINF) Q1 Earnings: Cat Loss to Hurt?
by Zacks Equity Research
Weak underwriting results and rising expenses might affect Cincinnati Financial's (CINF) Q1. However, improved premiums and growth in net investment income can be tailwinds.
Can Catastrophe Loss Mar Chubb's (CB) Q1 Earnings Prospects?
by Zacks Equity Research
Higher catastrophe loss and escalating expenses might affect Chubb's (CB) Q1 earnings performance.
Is a Beat in the Cards for Torchmark (TMK) in Q1 Earnings?
by Zacks Equity Research
Higher premiums at the Life Insurance and Health segments plus better investment results might aid Torchmark in (TMK) Q1.
Kemper (KMPR) Surges More Than 40% in a Year: Here's Why
by Zacks Equity Research
Kemper's (KMPR) solid fundamentals and efforts to reinforce portfolio pushed its share price over 40% in a year.
5 Factors That Make Aflac (AFL) an Attractive Bet for Now
by Zacks Equity Research
Aflac's (AFL) strong U.S. business, benefits from tax reform, capital strength and strong earnings projection make it an attractive pick for investors.
AIG to Buy Validus, Expand Reach in Reinsurance Business
by Zacks Equity Research
American International Group Inc. (AIG) has entered into a definitive agreement to buy Validus that validates its efforts to use its capital for inorganic growth.
MGIC Investment (MTG) Q4 Earnings Surpass, Revenues Miss
by Zacks Equity Research
MGIC Investment's (MTG) Q4 earnings outperformance reflects loss reduction. Also, net investment income and higher premiums improve.
Zacks Industry Outlook Highlights: Kemper, MGIC Investment, Hanover Insurance Group and Torchmark
by Zacks Equity Research
Zacks Industry Outlook Highlights: Kemper, MGIC Investment, Hanover Insurance Group and Torchmark
U.S. Insurance Stock Outlook - December 2017
by Kalyan Nandy
While the expected continuation of a benign credit environment will support the operating performance of life insurers, a strong capital base will help Property & Casualty (P&C) insurers combat losses from hurricanes and wildfires.
4 Top-Notch Insurance Stocks That Double the S&P 500 in 2017
by Zacks Equity Research
We zero in on four best insurance bets this year so far that double the S&P 500 index and raise substantial optimism among investors to reap benefits from.
Kemper (KMPR) & Subsidiaries' Ratings Retained By A.M. Best
by Zacks Equity Research
Kemper (KMPR) and units receive rating action from A.M. Best, which might help the Multi line insurer retain investors' faith and write more businesses in the future.
Is Kemper Corporation (KMPR) Stock a Solid Choice Right Now?
by Zacks Equity Research
Kemper Corporation (KMPR) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
MetLife (MET) Expands Coverage to Include Diabetic Patients
by Zacks Equity Research
The expansion of coverage by MetLife Hong Kong, a wholly owned subsidiary of MetLife (MET), intends to make medical facilities easily accessible for diabetic patients.
Prudential Financial's (PRU) Subordinated Notes Get Rated
by Zacks Equity Research
Ratings of Prudential Financial's (PRU) subordinated notes by credit rating agencies reflect its robust performance across all its segments.
Radian Group Raises Notes Offering to $450M, Gets Rated
by Zacks Equity Research
Radian Group (RDN) raises senior notes offering to fund tender offers as well buyback outstanding debts. The ratings by Moody's reflect the company's refined profitability standards.
MGIC Investment vs. Radian Group: Which Stock Fares Better?
by Zacks Equity Research
On comparative analysis, we try and find out which stock -- Radian Group (RDN) or MGIC Investment (MTG) -- is better positioned in terms of fundamentals.
Cigna's (CI) Unsecured Debts Receive Ratings From Moody's
by Zacks Equity Research
Unsecured debt ratings of Cigna assigned by Moody's reflect the company's robust business profile and wide national presence.
Add These 4 Insurance Outperformers to Boost Your Portfolio
by Zacks Equity Research
We zero in on four insurance industry outperformers -- American Financial (AFG), First American Financial (FAF), American Equity Investment (AEL) and Kemper (KMPR) -- that you may buy for better yields.